Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MARC1 downregulation reduces hepatocyte lipid content by increasing beta-oxidation.
Ciociola E, Dutta T, Sasidharan K, Kovooru L, Noto FR, Pennisi G, Petta S, Mirarchi A, Maurotti S, Scopacasa B, Tirinato L, Candeloro P, Henricsson M, Lindén D, Jamialahmadi O, Pujia A, Mancina RM, Romeo S. Ciociola E, et al. Among authors: pennisi g. Clin Mol Hepatol. 2024 Dec 23. doi: 10.3350/cmh.2024.0642. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39716370 Free article.
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization.
Pennisi G, Maurotti S, Ciociola E, Jamialahmadi O, Bertolazzi G, Mirarchi A, Bergh PO, Scionti F, Mancina RM, Spagnuolo R, Tripodo C, Boren J, Petta S, Romeo S. Pennisi G, et al. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1086-1097. doi: 10.1161/ATVBAHA.123.319789. Epub 2024 Feb 22. Arterioscler Thromb Vasc Biol. 2024. PMID: 38385290 Free article.
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Jamialahmadi O, Mancina RM, Ciociola E, Tavaglione F, Luukkonen PK, Baselli G, Malvestiti F, Thuillier D, Raverdy V, Männistö V, Pipitone RM, Pennisi G, Prati D, Spagnuolo R, Petta S, Pihlajamäki J, Pattou F, Yki-Järvinen H, Valenti L, Romeo S. Jamialahmadi O, et al. Among authors: pennisi g. Gastroenterology. 2021 Apr;160(5):1634-1646.e7. doi: 10.1053/j.gastro.2020.12.023. Epub 2021 Feb 6. Gastroenterology. 2021. PMID: 33347879 Free article.
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
Pipitone RM, Malvestiti F, Pennisi G, Jamialahmadi O, Dongiovanni P, Bertolazzi G, Pihlajamäki J, Yki-Järvinen H, Vespasiani-Gentilucci U, Tavaglione F, Maurotti S, Bianco C, Di Maria G, Enea M, Fracanzani AL, Kärjä V, Lupo G, Männistö V, Meroni M, Piciotti R, Qadri S, Zito R, Craxì A, Di Marco V, Cammà C, Tripodo C, Valenti L, Romeo S, Petta S, Grimaudo S. Pipitone RM, et al. Among authors: pennisi g. Liver Int. 2023 Aug;43(8):1761-1771. doi: 10.1111/liv.15586. Epub 2023 Apr 23. Liver Int. 2023. PMID: 37088979
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease.
Salomone F, Pipitone RM, Longo M, Malvestiti F, Amorini AM, Distefano A, Casirati E, Ciociola E, Iraci N, Leggio L, Zito R, Vicario N, Saoca C, Pennisi G, Cabibi D, Lazzarino G, Fracanzani AL, Dongiovanni P, Valenti L, Petta S, Volti GL, Grimaudo S. Salomone F, et al. Among authors: pennisi g. J Hepatol. 2024 Jan;80(1):10-19. doi: 10.1016/j.jhep.2023.09.020. Epub 2023 Oct 25. J Hepatol. 2024. PMID: 37890719
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19].
Salomone F, Pipitone RM, Longo M, Malvestiti F, Amorini AM, Distefano A, Casirati E, Ciociola E, Iraci N, Leggio L, Zito R, Vicario N, Saoca C, Männistö V, Pihlajamäki J, Qadri S, Yki-Järvinen H, Romeo S, Pennisi G, Cabibi D, Lazzarino G, Fracanzani AL, Dongiovanni P, Valenti L, Petta S, Volti GL, Grimaudo S. Salomone F, et al. Among authors: pennisi g. J Hepatol. 2024 Feb;80(2):378. doi: 10.1016/j.jhep.2023.12.002. Epub 2024 Jan 4. J Hepatol. 2024. PMID: 38182533 Free article. No abstract available.
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.
Pelusi S, Cespiati A, Rametta R, Pennisi G, Mannisto V, Rosso C, Baselli G, Dongiovanni P, Fracanzani AL, Badiali S, Maggioni M, Craxi A, Fargion S, Prati D, Nobili V, Bugianesi E, Romeo S, Pihlajamaki J, Petta S, Valenti L. Pelusi S, et al. Among authors: pennisi g. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2310-2319.e6. doi: 10.1016/j.cgh.2019.01.027. Epub 2019 Jan 29. Clin Gastroenterol Hepatol. 2019. PMID: 30708111 Free article.
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD.
Grimaudo S, Bartesaghi S, Rametta R, Marra F, Margherita Mancina R, Pihlajamäki J, Kakol-Palm D, Andréasson AC, Dongiovanni P, Ludovica Fracanzani A, Lori G, Männistö V, Pellegrini G, Bohlooly-Y M, Pennisi G, Maria Pipitone R, Spagnuolo R, Craxì A, Lindén D, Valenti L, Romeo S, Petta S. Grimaudo S, et al. Among authors: pennisi g. Liver Int. 2021 Feb;41(2):321-332. doi: 10.1111/liv.14711. Epub 2020 Nov 2. Liver Int. 2021. PMID: 33091218
266 results